NCT05770713View on ClinicalTrials.gov

A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

CompletedOBSERVATIONAL

Enrollment

48

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions

Breast Cancer

Trial Locations (1)

H9J2M5

Pfizer Canada, Kirkland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY